Company intelligence / Profile preview

СТМФАРМ

Izhevsk, Udmurt Republic, Russia
Ownership
Private
Development stage
Other
01

Overview

STM-PHARM (СТМФАРМ) is a Russian pharmaceutical company founded in 2014, specializing in the development, production, and distribution of a wide range of healthcare products, including medicines, dietary supplements, cosmetics, and medical devices. Originally established as a division of the Pharmaimpeks pharmacy chain, the company now operates independently and utilizes a contract manufacturing model with over 20 production sites across Russia, Europe, and Asia. Its extensive portfolio of over 600 products includes well-known brands such as Maxiflor (probiotics), Livesil (hepatoprotectors), and Trineuro (neurology). STM-PHARM focuses on therapeutic areas such as gastroenterology, neurology, phlebology, and respiratory health, supplying products to more than 20,000 pharmacies and major online marketplaces. The company maintains a strong focus on quality, selecting manufacturing partners certified under GMP, ISO, and FDA standards.

Therapeutic areas
ImmunologyCardiovascularNeurologyInfectious DiseasesPulmonologyRheumatologyGastroenterologyMetabolic Disorders
Modalities
Small moleculeMicrobial therapyPeptidesProtein
Industry
Biotech
02

Partnerships

Pharmaimpeks

Beyond the preview

Go deeper on СТМФАРМ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on СТМФАРМ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call